2011;342:d2392. 22. Strom BL, Abrutyn E, Berlin JA, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000;102:2842 8. 23. Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, et al. Infective endo- carditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation. 2015;131:1566 74. 24. Mangner N, Woitek F, Haussig S, et al. Incidence, predictors, and outcome of patients developing infective endocarditis following transfemoral trans- catheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2907 8. 25. Karavas AN, Filsoufi F, Mihaljevic T, et al. Risk factors and management of endocarditis after mitral valve repair. J Heart Valve Dis. 2002;11:660 4. 26. Gillinov AM, Faber CN, Sabik JF, et al. Endocarditis after mitral valve repair. Ann Thorac Surg. 2002;73:1813 6. 27. Botoman VA, Surawicz CM. Bacteremia with gastrointestinal endoscopic procedures. Gastrointest Endosc. 1986;32:342 6. 28. Low DE, Shoenut JP, Kennedy JK, et al. Risk of bacteremia with endoscopic sphincterotomy. Can J Surg. 1987;30:421 3. 29. Low DE, Shoenut JP, Kennedy JK, et al. Prospective assessment of risk of bacteremia with colonoscopy and polypectomy. Dig Dis Sci. 1987;32:1239 43. 30. Wolf JS, Bennett CJ, Dmochowski RR, et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008;179:1379 90. 2.4.3. Anticoagulation for AF in Patients With VHD 1. Pan K-L, Singer DE, Ovbiagele B, et al. Effects of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis. J Am Heart Assoc. 2017;6:e005835. 2. Lip GYH, Jensen M, Melgaard L, et al. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating valvular heart disease in a nationwide cohort study. Europace. 2019;21: 33 40. 3. Vora AN, Dai D, Matsuoka R, et al. 